Drug profile · INN
trabectedin
YONDELIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trabectedin (YONDELIS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN trabectedin
Brand YONDELIS
Route INJECTION
Formulation POWDER
ATC code L01CX01
Originator Lacuna Pharma Pty Ltd
Frequently asked questions
What is trabectedin?
trabectedin (YONDELIS) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for trabectedin?
YONDELIS is a marketed brand name for trabectedin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trabectedin?
trabectedin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.